NUS PE Ratio & Valuation, Is NUS Overvalued

Historical Valuation

NU Skin Enterprises Inc (NUS) is now in the Fair zone, suggesting that its current forward PE ratio of 7.34 is considered Fairly compared with the five-year average of 12.18. The fair price of NU Skin Enterprises Inc (NUS) is between 7.27 to 14.68 according to relative valuation method.

Relative Value

Fair Zone

7.27-14.68

Current Price：7.37

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is NU Skin Enterprises Inc (NUS) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

NU Skin Enterprises Inc (NUS) has a current Price-to-Book (P/B) ratio of 0.59. Compared to its 3-year average P/B ratio of 0.92, the current P/B ratio is approximately -35.46% higher. Relative to its 5-year average P/B ratio of 1.61, the current P/B ratio is about -63.16% higher. NU Skin Enterprises Inc (NUS) has a Forward Free Cash Flow (FCF) yield of approximately 11.29%. Compared to its 3-year average FCF yield of 12.65%, the current FCF yield is approximately -10.76% lower. Relative to its 5-year average FCF yield of 9.57%, the current FCF yield is about 18.05% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for NUS competitors is 0.31, providing a benchmark for relative valuation. NU Skin Enterprises Inc Corp (NUS.N) exhibits a P/S ratio of 0.31, which is 0.94% above the industry average. Given its robust revenue growth of -16.89%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of NUS increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of NUS in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is NUS currently overvalued or undervalued?

What is NU Skin Enterprises Inc (NUS) fair value?

NUS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of NU Skin Enterprises Inc (NUS) is between 7.27 to 14.68 according to relative valuation method.

How does NUS's valuation metrics compare to the industry average?

The average P/S ratio for NUS's competitors is 0.31, providing a benchmark for relative valuation. NU Skin Enterprises Inc Corp (NUS) exhibits a P/S ratio of 0.31, which is 0.94% above the industry average. Given its robust revenue growth of -16.89%, this premium appears unsustainable.

What is the current P/B ratio for NU Skin Enterprises Inc (NUS) as of Mar 11 2026?

As of Mar 11 2026, NU Skin Enterprises Inc (NUS) has a P/B ratio of 0.59. This indicates that the market values NUS at 0.59 times its book value.

What is the current FCF Yield for NU Skin Enterprises Inc (NUS) as of Mar 11 2026?

As of Mar 11 2026, NU Skin Enterprises Inc (NUS) has a FCF Yield of 11.29%. This means that for every dollar of NU Skin Enterprises Inc's market capitalization, the company generates 11.29 cents in free cash flow.

What is the current Forward P/E ratio for NU Skin Enterprises Inc (NUS) as of Mar 11 2026?

As of Mar 11 2026, NU Skin Enterprises Inc (NUS) has a Forward P/E ratio of 7.34. This means the market is willing to pay $7.34 for every dollar of NU Skin Enterprises Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for NU Skin Enterprises Inc (NUS) as of Mar 11 2026?

As of Mar 11 2026, NU Skin Enterprises Inc (NUS) has a Forward P/S ratio of 0.31. This means the market is valuing NUS at $0.31 for every dollar of expected revenue over the next 12 months.

NUS Valuation